Clover Health Investments, CORP /DE Form 4 insider transactions

Andrew Toy, CEO of Clover Health, disposed of shares to cover tax obligations upon the vesting of restricted stock units.

Karen Soares, General Counsel & Secretary of Clover Health Investments, disposed of 27,293 shares of Class A Common Stock on April 30, 2025, to cover tax obligations related to vesting restricted stock units.

Conrad Wai, CEO of Counterpart Health (a division of Clover Health Investments), reports the disposal of 26,593 shares of Class A Common Stock to cover tax obligations upon vesting of restricted stock units.

Clover Health CEO Jamie Reynoso sold 25,659 shares of Class A Common Stock on April 30, 2025, to cover tax obligations related to the vesting of restricted stock units.

Brady Priest, CEO of Home Care at Clover Health Investments, disposed of 25,080 shares of Class A Common Stock to cover tax obligations upon vesting of restricted stock units.

Clover Health's CFO, Peter Kuipers, disposed of shares to cover tax obligations upon the vesting of restricted stock units.

Brady Priest, CEO of Home Care at Clover Health, disposed of shares to cover tax obligations upon the vesting of restricted stock units.

Jamie Reynoso, CEO of Clover Health, reports the disposal of shares to cover tax obligations related to vesting restricted stock units.

Andrew Toy, CEO of Clover Health, disposed of shares to cover tax obligations arising from the vesting of restricted stock units.

Karen Soares, General Counsel & Secretary of Clover Health Investments, reports the disposal of shares to cover tax obligations upon vesting of restricted stock units.

CEO of Clover Health, Jamie Reynoso, disposed of shares to cover tax obligations related to vesting restricted stock units.

Conrad Wai, CEO of Counterpart Health and an officer of Clover Health Investments, sold shares to cover tax obligations upon the vesting of restricted stock units.

Director Carladenise Edwards sold 200,000 shares of Clover Health Investments, CORP. on March 7, 2025, at an average price of $3.61 per share.

Clover Health's CEO of Home Care, Brady Patrick Priest, sold 75,000 shares of Class A Common Stock at an average price of $3.68 on March 6, 2025.

Karen Soares, General Counsel & Secretary of Clover Health Investments, sold 52,500 shares of Class A Common Stock on March 6, 2025, at a price of $3.8 per share.

Karen Soares, General Counsel & Secretary of Clover Health Investments, reports the disposal of shares to cover tax obligations upon vesting of restricted stock units.

Andrew Toy, CEO of Clover Health, disposed of shares to cover tax obligations related to the vesting of restricted stock units.

Karen Soares, General Counsel & Secretary of Clover Health Investments, reports the disposal of shares to cover tax obligations upon vesting of restricted stock units.

Jamie Reynoso, CEO of Medicare Advantage at Clover Health, disposed of 21,578 shares of Class A Common Stock on January 31, 2025, to cover tax obligations related to vesting restricted stock units.

Brady Priest, CEO of Home Care at Clover Health, disposed of 18,987 shares of Class A Common Stock on January 31, 2025, to cover tax obligations related to vesting restricted stock units.

CEO of Clover Health, Conrad Wai, disposed of 24,470 shares of Class A Common Stock to cover tax obligations arising from the vesting of restricted stock units.

Brady Priest, CEO of Home Care at Clover Health, disposed of 38,560 shares of Class A Common Stock on January 18, 2025, to cover tax obligations related to vesting restricted stock units.

Director Vivek Garipalli of Clover Health Investments, Corp. executed transactions involving Class A and Class B common stock following the vesting of restricted stock units.

Karen Soares, General Counsel & Secretary of Clover Health Investments, sold shares to cover tax obligations related to vesting restricted stock units.

Jamie Reynoso, CEO of Clover Health, disposed of 17,142 shares of Class A Common Stock on January 7, 2025, to cover tax obligations related to vesting restricted stock units.

Director Carladenise Edwards reports acquisition of 60,975 Class A Common Stock restricted stock units (RSUs) in Clover Health Investments, Corp.

William G. Robinson Jr., a director at Clover Health Investments, acquired 60,975 shares of Class A Common Stock through the vesting of restricted stock units.

Director Thomas L. Tran acquired 60,975 shares of Clover Health Class A Common Stock through a restricted stock unit grant that vests on January 6, 2026.

Director Anna U. Loengard reports acquisition of restricted stock units and adjustments to indirect beneficial ownership of Clover Health Investments Corp. shares.

Director Lee Shapiro reports acquisition of 60,975 Class A Common Stock units from Clover Health Investments, Corp.